Home
/
10x Genomics, Inc.
/
Financials
/
Quarterly
10x Genomics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that 10x Genomics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2020
Mar 31, 2020
$71.91M
May 12, 2020
Q3
2019
Sep 30, 2019
$61.21M
Nov 12, 2019
Q1
2020
Mar 31, 2019
$53.58M
May 12, 2020
Q3
2019
Sep 30, 2018
$36.61M
Nov 12, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$149.00M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$172.91M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$154.88M
May 9, 2025
Q3
2025
Sep 30, 2024
$151.65M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$153.10M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$141.01M
May 9, 2025
Q3
2024
Sep 30, 2023
$153.64M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$146.82M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$134.29M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$131.07M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$114.61M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$114.50M
May 4, 2023
Q3
2022
Sep 30, 2021
$125.30M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$115.84M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$105.82M
May 5, 2022
Q3
2021
Sep 30, 2020
$71.82M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$42.91M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$71.91M
May 7, 2021
Q3
2020
Sep 30, 2019
$61.21M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$55.82M
Aug 12, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($27.47M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
$34.54M
Aug 8, 2025
Q3
2025
Jun 30, 2025
$34.54M
Nov 7, 2025
Q2
2025
Mar 31, 2025
($34.36M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($34.36M)
May 9, 2025
Q3
2025
Mar 31, 2025
($34.36M)
Nov 7, 2025
Q3
2025
Sep 30, 2024
($35.75M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($37.90M)
Aug 8, 2025
Q3
2025
Jun 30, 2024
($37.90M)
Nov 7, 2025
Q3
2025
Mar 31, 2024
($59.95M)
Nov 7, 2025
Q1
2025
Mar 31, 2024
($59.95M)
May 9, 2025
Q2
2025
Mar 31, 2024
($59.95M)
Aug 8, 2025
Q3
2024
Sep 30, 2023
($92.99M)
Oct 29, 2024
Q3
2024
Jun 30, 2023
($62.41M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($62.41M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($50.75M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($50.75M)
Apr 30, 2024
Q3
2024
Mar 31, 2023
($50.75M)
Oct 29, 2024
Q3
2023
Sep 30, 2022
($41.91M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($64.46M)
Aug 4, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($32.24M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
$30.13M
Aug 8, 2025
Q1
2025
Mar 31, 2025
($39.33M)
May 9, 2025
Q3
2025
Sep 30, 2024
($41.49M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($41.74M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($61.50M)
May 9, 2025
Q3
2024
Sep 30, 2023
($94.80M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($63.36M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($51.99M)
Apr 30, 2024
Q3
2023
Sep 30, 2022
($40.00M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($63.12M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($41.74M)
May 4, 2023
Q3
2022
Sep 30, 2021
($15.88M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($10.33M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($10.22M)
May 5, 2022
Q3
2021
Sep 30, 2020
($65.26M)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($39.42M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($19.88M)
May 7, 2021
Q3
2020
Sep 30, 2019
($9.10M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($10.36M)
Aug 12, 2020